Agilent Technologies is positioned as a leader in the intersection of biotechnology, health care, life sciences, and pharmaceutical industries. Founded in 1999, this United States-based company is dedicated to transforming scientific endeavors into tangible solutions that impact global health and environmental sustainability.
Their slogan, "Let’s Bring Great Science to Life," encapsulates their mission. Agilent provides a comprehensive suite of advanced analytical, research, and diagnostic tools. Their offerings cater to sectors ranging from cancer treatment to alternative energy solutions. A key differentiator is Agilent’s CrossLab and technical teams, whose expertise enables clients to optimize laboratory operations, thereby enhancing focus on scientific advancements.
Financially solid, Agilent Technologies reported 2022 fiscal revenue of US $6.85 billion. Their latest financing round was a $500.00M Post IPO Debt investment in September 2019, underscoring continued investor confidence.